Form 4 for ATRA Atara Biotherapeutics, Inc.
Accepted 2021-11-05 00:00:00 ET · period of report 2021-11-04 · accession 0001567619-21-019403 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-11-05 | 2021-11-04 | ATRA | Fust Matthew K | Dir | S - Sale | $19.50 | -13.4K | 31.5K | -30% | -$260.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-04 | S | D | 13,354 | $19.50 | 31,500 | D | — | — |